Improvements in nondystrophic myotonias symptoms are similar for lamotrigine and mexiletine, according to a study pu ...

A UCL study found that lamotrigine is as effective as mexiletine for treating non-dystrophic myotonia, a rare muscle disorder ...

The study, published in Lancet Neurology, detailed the "head-to-head" trial implemented by the researchers to test two drugs, ...

A common drug used to treat epilepsy and certain mood disorders, called lamotrigine, has shown great promise as a new ...

Lamotrigine, commonly used for epilepsy and mood disorders, has shown promise as a treatment for non-dystrophic myotonia, a ...

Alembic has a cumulative total of 216 ANDA approvals (188 final approvals and 28 tentative approvals) from USFDA.

In this paper, we review the case of studies with lamotrigine in bipolar disorder, describing evidence of lack of efficacy in multiple mood states outside of the primary area of efficacy ...

This approval enhances Alembic Pharma’s portfolio, which now totals 216 ANDAs from the USFDA, including 188 final and 28 ...

The study, published in Lancet Neurology, detailed the "head-to-head" trial implemented by the researchers to test two drugs, ...

The approved ANDA is therapeutically equivalent to GlaxoSmithKline LLC's Lamictal XR extended-release tablets in strength of ...

This latest research on non-dystrophic myotonia offers promising results for those affected by the condition. Published in ...

A study tested the effectiveness of mexiletine and lamotrigine in treating non-dystrophic myotonia. Results indicated that ...